GMR outside the limits when using ABEL [Study As­sess­ment]

posted by Averroes – Spain, 2017-05-19 13:53 (2857 d 17:36 ago) – Posting: # 17372
Views: 7,404

Dear Helmut,

Recently we performed a full replicate (4-period) study using ABEL for EMA and actually the results shows AUC within 80-125, Cmax within expanded CI but unfortunately GMR fall outside 80-125.

I found in the forum that the GMR constrant is there for political reasons more than for scienfic or statistical reasons. Do you think we could still have an opportunity with European regulatory agencies?

Thanks,

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,667 registered users;
54 visitors (0 registered, 54 guests [including 11 identified bots]).
Forum time: 06:30 CET (Europe/Vienna)

They must find it difficult…; those who have taken authority as the truth,
rather than truth as the authority.    Gerald Massey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5